ADVANCED NSCLC

Clinical trials for ADVANCED NSCLC explained in plain language.

Never miss a new study

Get alerted when new ADVANCED NSCLC trials appear

Sign up with your email to follow new studies for ADVANCED NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1 Terminated 1

Experimental lung cancer drug trial halted early

Disease control Terminated

This study tested an experimental drug, REGN5093-M114, for people with advanced non-small cell lung cancer that has too much MET protein. The goal was to find a safe dose and see if the drug could shrink tumors, either alone or with another drug called cemiplimab. The study was t…

Matched conditions: ADVANCED NSCLC

Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control

Last updated May 17, 2026 04:33 UTC

ADVANCED NSCLC

Get alerted when new ADVANCED NSCLC trials appear

Experimental lung cancer drug trial halted early